Skip to main content
OpenTrials

Clinical trial condition

Pathologic Processes

Explore clinical trials studying Pathologic Processes. Study availability and eligibility vary by location and protocol.

141 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Pathologic Processes trial results

Recruiting

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

NCT07197944

Conditions
Digestive System Diseases, Disease, Gastrointestinal Diseases, +10 more
Locations
  • Washington University Center for Advanced Medicine St Louis, Missouri, United States
  • Lied Transplant Center at Nebraska Medical Center Omaha, Nebraska, United States
  • New York Presbyterian Hospital-Columbia University Medical Center New York, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View all 31 locations
View Trial Details
Recruiting

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

NCT07555483

Conditions
Alpha 1 Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • GC2501 Study Site 106 Birmingham, Alabama, United States
  • GC2501 Study Site 102 Phoenix, Arizona, United States
  • GC2501 Study Site 107 Scottsdale, Arizona, United States
  • GC2501 Study Site 100 Los Angelas, California, United States
View all 22 locations
View Trial Details
Recruiting

Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

NCT07654283

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of Maryland Baltimore, Maryland, United States
  • NYU Langone Health New York, United States
  • Texas Liver Institute San Antonio, Texas, United States
View Trial Details
Recruiting

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

NCT07370207

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • St Vincents Hospital Melbourne Fitzroy, Victoria, Australia
  • Queen Mary Hospital - PPDS Hong Kong, China
  • New Zealand Clinical Research Grafton, Auckland, New Zealand
  • National University Hospital - Singapore Singapore
View Trial Details
Recruiting

A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)

NCT07431112

Conditions
Alpha 1 Antitrypsin Deficiency, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Clinical Study Center Melbourne, Australia
  • Clinical Study Center 1 Tbilisi, Georgia
  • Clinical Study Center 2 Tbilisi, Georgia
  • Clinical Study Center Cambridge, United Kingdom
View Trial Details
Recruiting

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT07216443

Conditions
Acute Disease, Bone Marrow Diseases, Disease, +24 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • Weill Cornell Medicine - New York Presbyterian Hospital New York, United States
View Trial Details

Related conditions